Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
hypertensive252 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00363 | 35119232 | J Basic Clin Physiol Pharmacol | Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. | 2022 | Details |
| A00529 | 35052872 | Biomedicines | Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. | 2022 | Details |
| A00812 | 34959080 | J Neurol Sci | Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations. | 2021 | Details |
| A00945 | 34922644 | Lancet Diabetes Endocrinol | Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia. | 2021 | Details |
| A01125 | 34862599 | Br J Pharmacol | Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. | 2022 | Details |
| A01133 | 34860208 | J Occup Environ Med | Determination of Cardiovascular Risk in 56,262 Spanish Construction Workers: Cardiovascular Risk in Construction Workers. | 2021 | Details |
| A01463 | 34738990 | J Hypertens | Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. | 2021 | Details |
| A01718 | 34641807 | BMC Geriatr | A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80. | 2021 | Details |
| A02015 | 34530527 | Clin Mol Hepatol | Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. | 2021 | Details |
| A02110 | 34503976 | Mol Pharmacol | Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene. | 2021 | Details |
| A02567 | 34326946 | World J Diabetes | Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. | 2021 | Details |
| A02656 | 34295987 | Clin Exp Hepatol | Correlation of endoscopic findings with Doppler ultrasound in portal hypertension in children. | 2021 | Details |
| A02744 | 34262716 | Food Sci Nutr | Effect of garlic powder supplementation on blood pressure and hs-C-reactive protein among nonalcoholic fatty liver disease patients: A randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02990 | 34171957 | Vnitr Lek | The use of moxonidine in the treatment of arterial hypertension. | 2021 | Details |
| A03086 | 34136497 | Front Med (Lausanne) | Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. | 2021 | Details |
| A03289 | 34059612 | Curr Opin Cardiol | Update on cardiovascular risk in nonalcoholic fatty liver disease. | 2021 | Details |
| A03331 | 34041187 | J Family Med Prim Care | Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi. | 2021 | Details |
| A03377 | 34025131 | J Ginseng Res | Effect of Korean Red Ginseng on metabolic syndrome. | 2020 | Details |
| A04039 | 33780129 | Am J Transplant | Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications. | 2021 | Details |
| A04490 | 33598084 | Pan Afr Med J | Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes. | 2020 | Details |
| A04698 | 33536442 | Sci Rep | Clinical implications of renin-angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A04867 | 33475584 | J Pak Med Assoc | Association of apoptotic marker cytokeratin18 with blood pressure in nonalcoholic fatty liver disease patients. | 2020 | Details |
| A04889 | 33465483 | Clin Gastroenterol Hepatol | NAFLD Cirrhosis Is Rising Among Childbearing Women and Is the Most Common Cause of Cirrhosis in Pregnancy. | 2021 | Details |
| A04890 | 33465383 | Complement Ther Med | Effects of artichoke on blood pressure: A systematic review and meta-analysis. | 2021 | Details |
| A05003 | 33417955 | Life Sci | Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats. | 2021 | Details |
| A05278 | 33315911 | PLoS One | The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension. | 2020 | Details |
| A05495 | 33233601 | Diagnostics (Basel) | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis. | 2020 | Details |
| A05530 | 33217178 | Liver Transpl | Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. | 2021 | Details |
| A05610 | 33190175 | Obes Surg | Development and Validation of a Predictive Model of Success in Bariatric Surgery. | 2020 | Details |
| A06148 | 32987175 | Ann Hepatol | Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases. | 2020 | Details |
| A06168 | 32980956 | Dig Dis Sci | Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19. | 2020 | Details |
| A06286 | 32941676 | J Clin Hypertens (Greenwich) | Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. | 2020 | Details |
| A06336 | 32924000 | Metabol Open | The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. | 2020 | Details |
| A06678 | 32783310 | Int J Exp Pathol | A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. | 2020 | Details |
| A06700 | 32775974 | JHEP Rep | Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. | 2020 | Details |
| A06815 | 32736956 | Nutr Metab Cardiovasc Dis | Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. | 2020 | Details |
| A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
| A06965 | 32684739 | World J Gastroenterol | Medications in type-2 diabetics and their association with liver fibrosis. | 2020 | Details |
| A06993 | 32668632 | Int J Mol Sci | Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? | 2020 | Details |
| A07064 | 32636123 | Nutr Metab Cardiovasc Dis | PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome. | 2020 | Details |
| A07175 | 32592657 | Cell Metab | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. | 2020 | Details |
| A07206 | 32583511 | Hepatol Res | Liver disease in pregnancy. | 2020 | Details |
| A07339 | 32531415 | J Hepatol | Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. | 2020 | Details |
| A07824 | 32344052 | J Hepatol | Liver-related mortality is similar among men and women with cirrhosis. | 2020 | Details |
| A07949 | 32302265 | Circ Res | Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. | 2020 | Details |
| A08495 | 32086988 | Liver Int | Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients. | 2020 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09612 | 31675274 | Metab Syndr Relat Disord | Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. | 2019 | Details |
| A09812 | 31601203 | BMC Endocr Disord | Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. | 2019 | Details |
| A09916 | 31562685 | J Hepatobiliary Pancreat Sci | Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model. | 2019 | Details |
| A10018 | 31523440 | BMJ Open Gastroenterol | Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. | 2019 | Details |
| A10139 | 31470786 | Curr Pharm Des | A Mitochondrial Approach to Cardiovascular Risk and Disease. | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10791 | 31191364 | Front Physiol | Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes. | 2019 | Details |
| A10907 | 31131153 | Am J Cardiovasc Dis | Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits. | 2019 | Details |
| A10918 | 31124886 | J Pediatr Gastroenterol Nutr | Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11506 | 30867987 | PeerJ | Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction. | 2019 | Details |
| A11792 | 30740871 | Diabetes Metab Res Rev | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. | 2019 | Details |
| A11923 | 30680827 | Int J Exp Pathol | Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model. | 2019 | Details |
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A12569 | 30387292 | J Diabetes Investig | Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men. | 2018 | Details |
| A12974 | 30201044 | Biol Sex Differ | Sex-specific differences in hepatic steatosis in obese spontaneously hypertensive (SHROB) rats. | 2018 | Details |
| A13291 | 30048367 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? | 2018 | Details |
| A13672 | 29845719 | Intern Med J | Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence. | 2018 | Details |
| A13971 | 29664906 | PLoS One | Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study. | 2018 | Details |
| A14009 | 29636553 | Hypertens Res | The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. | 2018 | Details |
| A14031 | 29626047 | BMJ Open | Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. | 2018 | Details |
| A14179 | 29549269 | Sci Rep | Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. | 2018 | Details |
| A14378 | 29438418 | PLoS One | Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet. | 2018 | Details |
| A14573 | 29348103 | Pak J Pharm Sci | Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan. | 2018 | Details |
| A14836 | 29210656 | Curr Vasc Pharmacol | Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment. | 2018 | Details |
| A14944 | 29162773 | J Atheroscler Thromb | A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats. | 2017 | Details |
| A15437 | 28906458 | Nutrients | Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways. | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15871 | 28676027 | Curr Vasc Pharmacol | The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options? | 2018 | Details |
| A15883 | 28673635 | J Pharmacol Sci | Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet. | 2017 | Details |
| A15889 | 28669329 | Curr Vasc Pharmacol | Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. | 2018 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15898 | 28663676 | J Clin Exp Hepatol | Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? | 2017 | Details |
| A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
| A16097 | 28573066 | World J Gastrointest Pathophysiol | Embrionary way to create a fatty liver in portal hypertension. | 2017 | Details |
| A16355 | 28441694 | J Hypertens | Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. | 2017 | Details |
| A16658 | 28260764 | Mymensingh Med J | Sonographically Detected Non Alcoholic Fatty Liver Disease in Apparently Healthy Adults and Associated Factors. | 2017 | Details |
| A17456 | 27779710 | Mol Med Rep | Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and -10 in spontaneously hypertensive rats with steatohepatitis. | 2016 | Details |
| A17679 | 27663794 | BMC Cardiovasc Disord | The interaction effects of risk factors for hypertension in adults: a cross-sectional survey in Guilin, China. | 2016 | Details |
| A17869 | 27513394 | Turk J Med Sci | The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17902 | 27487534 | Wiad Lek | Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride. | 2018 | Details |
| A17973 | 27442673 | Medicine (Baltimore) | Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal. | 2016 | Details |
| A18092 | 27354356 | Prostaglandins Other Lipid Mediat | EETs and HO-1 cross-talk. | 2016 | Details |
| A18134 | 27328504 | Clin Exp Obstet Gynecol | Late gestational liver dysfunction and its impact on pregnancy outcomes. | 2016 | Details |
| A18420 | 27146015 | Annu Rev Nutr | Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. | 2016 | Details |
| A18521 | 27074921 | Dig Dis Sci | Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. | 2016 | Details |
| A18608 | 27037502 | Int J Exp Pathol | Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet. | 2016 | Details |
| A18631 | 27023537 | Int J Mol Sci | Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients. | 2016 | Details |
| A18693 | 26997011 | Indian J Med Res | Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18803 | 26932594 | Hepatol Res | Hypertension and non-alcoholic fatty liver disease proven by transient elastography. | 2016 | Details |
| A18900 | 26880573 | J Hepatobiliary Pancreat Sci | Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease. | 2016 | Details |
| A18982 | 26834493 | Clin Exp Gastroenterol | Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. | 2016 | Details |
| A18986 | 26831610 | Saudi J Gastroenterol | Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial. | 2017 | Details |